13 episodes

eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
See acast.com/privacy for privacy and opt-out information.

eMultipleSclerosis Review eMultipleSclerosis Review

    • Health & Fitness
    • 5.0 • 1 Rating

eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.
See acast.com/privacy for privacy and opt-out information.

    Shared Decision Making in MS: The Why and The How

    Shared Decision Making in MS: The Why and The How

    Shared decision-making — what does it mean in multiple sclerosis? Can it really help providers more fully understand their patients’ concerns? Can it motivate patients to more readily and enthusiastically take ownership of their disease? And most important, how can it be developed in the clinic? 
    Join us in this eMultipleSclerosis Review podcast, as we talk about the why and how of shared decision-making in MS with PA Lisa Fox from the Department of Neurology at Johns Hopkins Hospital in Baltimore.  
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 21 min
    Clinical Approaches and DMT Choices

    Clinical Approaches and DMT Choices

    As the number of new MS therapies continues to grow, so does the uncertainty about which management approach — escalation or highly effective disease-modifying therapy — is best for each patient. What are the patient-specific factors that indicate the most appropriate DMT selection? What’s known about the potential longer-term risks associated with highly effective therapies? 
    That’s the focus of our discussion with Dr. Yujie Wang from the University of Washington and Johns Hopkins University, and Dr. Anne Damian-Yacoub from Johns Hopkins University in this eMultipleSclerosis Review podcast. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 23 min
    A Clinical Approach to Comprehensive MS Care

    A Clinical Approach to Comprehensive MS Care

    A “comprehensive MS center” — what is it? Which clinicians comprise a “multidisciplinary MS care team?” How does comprehensive MS care work in practice? How does it benefit patients?
    That’s the focus of this non-CME-accredited eMultipleSclerosis Review podcast, where we answer those questions and more, with our special guest, Dr. Jacqueline Nicholas, System Chief of Neuroimmunology and Multiple Sclerosis at the OhioHealth Multiple Sclerosis Center.  
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 31 min
    Clinical Challenges of Pediatric MS

    Clinical Challenges of Pediatric MS

    Pediatric multiple sclerosis. How different is the disease from adult MS? Which disease-modifying therapies have been trialed and approved for use in children? How common is cognitive impairment in children with MS? How can it be successfully addressed?  
    These are some of the important questions Drs. Zongqi Xia and Kavita Thakkar from the University of Pittsburgh Medical Center discuss in this clinically focused eMultipleSclerosis Review podcast. 
    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 20 min
    Clinical Decisions: Selecting the Right Disease Modifying Therapy

    Clinical Decisions: Selecting the Right Disease Modifying Therapy

    Selecting the most appropriate Disease Modifying Therapy (DMT) is becoming more complicated for patients with MS and clinicians who treat them. Newer approaches and newer agents are altering the benefit/risk equation, and making the question of which treatment is most appropriate for which patient more difficult to answer. 

    That’s the focus of our discussion with Dr. Erin Longbrake, Assistant Professor of Neurology and Director of the Multiple Sclerosis Fellowship Program at Yale University, in this eMultipleSclerosis Review podcast. 

    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 21 min
    Clinic Insight — Managing Chronic MS Symptoms

    Clinic Insight — Managing Chronic MS Symptoms

    Successful management of multiple sclerosis has gone beyond slowing disease progression and preventing relapses. Improving patients’ health-related quality of life by recognizing and addressing the pervasive chronic symptoms of the disease — spasticity, fatigue, depression, cognitive dysfunction — has become increasingly important.
    In this eMultipleSclerosis Review Podcast, Dr. Bardia Nourbakhsh from the Johns Hopkins School of Medicine provides clinical insight into reducing the disease burden of these common symptoms. 

    Take our post-test to claim CME credits.
    To read a companion newsletter click here.

    See acast.com/privacy for privacy and opt-out information.

    • 17 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Health & Fitness